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ABSTRACT 
Background: Leuko-araiosis (LA) and dementia are common geriatric conditions but their pathogenesis and clinical 
significance are not completely understood. An evaluation of CT perfusion (CTP) in both these conditions can further 
enhance the understanding of these diseases. 
Methods: Twenty-one patients with LA and 21 age-matched controls were studied with CTP and assessed for their 
cognitive function. The subjects were classified into four groups: Group 1, with LA (n = 21); Group 2, without LA (n = 
21); Group 3, with dementia (n = 7); Group 4, without dementia (n = 11). The mean cerebral blood flow (CBF), cerebral 
blood volume (CBV) and mean transit time (MTT) values were compared between groups 1 and 2, while mean CBF 
values were compared between groups 3 and 4. 
Results: Mean white matter CBF was considerably reduced in
 patients with LA in the frontal region by 42% (p = 
0.000), basal ganglia by 37% (p = 0.000) and occipital region by 18% (p = 0.019). The mean white matter CBV was 
reduced in
 patients with LA in the frontal region by 36% (p = 0.000) and basal ganglia by 28% (p = 0.017). The mean 
white matter CBF was dramatically reduced in
 patients with dementia in the frontal region by 44% (p = 0.000), basal 
ganglia by 32% (p = 0.038) and occipital regions by 24% (p = 0.001). 
Conclusion: The CTP showed reduced white matter CBF and CBV in patients with LA. This is consistent with 
chronic ischemia as the pathogenesis of LA. The CTP is also a potentially important technique in the diagnosis and 
management of dementia, because of its ability to reveal cerebral hypoperfusion. © 2006 Biomedical Imaging and 
Intervention Journal. All rights reserved. 
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INTRODUCTION 
Leuko-araiosis  (LA)  is  the  term  introduced  by 
Hachinski et al to designate periventricular or subcortical 
(centrum semiovale) areas of hypodensity on computed 
tomography  (CT)  or  hyperintensity  on  T2-weighted 
magnetic  resonance  imaging  (MRI).  LA  is  a  common 
condition, with epidemiological studies demonstrating a 
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high  prevalence  in  subjects  over  65  years  of  age,  as 
evaluated  by  CT  or  MRI.  It  is  probably  caused  by 
chronic  cerebral  ischemia  but  the  pathogenesis  and  its 
clinical  significance  are  not  completely  understood. 
Some  individuals  remain  asymptomatic  for  prolonged 
periods, while others develop gait disturbance, cognitive 
impairment,  mood  disorders,  disability,  and  even 
dementia. LA increases overall morbidity and mortality 
and also the risk of stroke. Further understanding of the 
pathogenesis of LA is essential because it is potentially 
preventable and modifiable [1,2]. 
Dementia  is  a  highly  widespread  and  morbid 
condition  frequently  found  in  the  elderly,  especially 
those  affected  by  LA.  Clinical  identification  and 
diagnosis  of  dementia  or  predementia  is  especially 
difficult  in  the  early  stages.  However,  the  early  and 
accurate diagnosis is important because early treatment is 
now possible. Functional brain imaging techniques such 
as PET and SPECT can provide substantial assistance in 
the initial diagnosis of dementia, but are limited because 
of factors such as low availability and high costs [3,4,5].  
Recent  developments  in  helical  and  high-speed 
continuous  data  technology  have  enabled  CTP  using 
iodinated contrast material. CTP of the brain is a proven 
tool, especially in acute stroke and oncology cases [6,7]. 
With the evolution of spiral multi-slice CT technology 
and its increasing availability, CTP can play an important 
role  in  clinical  techniques.  Our  study  examined  the 
correlation of cerebral perfusion with LA and dementia, 
to  prove  that  the  pathogenesis  of  the  LA  is  chronic 
cerebral ischaemia. We also tested the hypotheses, that 
the mean cerebral blood flow (CBF) in the cerebral white 
matter  in  patients  with  LA  is  lower  than  in  patients 
without, within the same age group; and that the mean 
CBF  in  the  cerebral  white  matter  of  patients  with 
dementia is lower than in patients without. 
MATERIALS AND METHODOLOGY 
Subjects 
The subjects were selected from a group of patients 
who were referred to our department for CT examination 
of the brain. The reasons for referral were stroke (n = 
18),  dementia  or  cognitive  impairment  (n  =  14), 
headache (n = 6), giddiness (n = 5), psychiatric disorder 
(n = 4), syncope (n = 1) and metastatic malignancy of the 
brain  (n  =1).  The  subjects were  selected  based  on  the 
identification  of  LA  in  non-contrasted  CT  brain  using 
standard window (Figure 1). A total of 23 patients with 
LA were identified and they underwent CTP on the same 
day as the scam. A total of 26 patients without LA were 
also selected for CTP as an age-matched control sample. 
All  subjects  were  assessed  with  Mini  Mental  State 
Examination  (MMSE)  either  before  or  after  the 
procedure. Patients with an MMSE score of less than 24 
and  with  clinical  features  of  dementia  or  cognitive 
impairment were used for the sample with dementia. The 
following  information  was  collected  from  the  patients: 
age, sex and risk factors (diabetes mellitus, hypertension 
and cardiovascular disease). Based on the non-contrasted 
CT  findings  and  MMSE  scores,  the  subjects  were 
classified into four groups: Group 1, patients with LA (n 
= 21, 10 Male, 11 Female); Group 2, patients without LA 
(n  =  21,  9  Male,  12  Female);  Group  3,  patients  with 
dementia (n = 7, 3 Male, 4 Female; 3 with LA, 4 without 
LA); Group 4, patients without dementia (n = 11, 6 Male, 
5 Female; all with no LA).  
The  clearance  from  the  Ethical  Committee  was 
obtained prior to the commencement of this study, along 
with informed consent from the subjects or their next of 
kin.  Those  patients  with  contraindication  to  contrast 
agents,  history  of  allergy,  renal  impairment,  or  with 
intracranial  bleed  or  massive  mass  effect  on  non-
contrasted CT brain were excluded from the study. 
 
Figure 1 Plain CT brain at the basal ganglia (A) and corona radiata (B) levels showing periventricular 
white matter lucency in a patient with leuko-araiosis. N Ramli et al. Biomed Imaging Interv J 2006; 2(2):e16    3 
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Scanning Technique 
All CT examinations were performed on a 16 slice 
multidetector CT scanner (GE Lightspeed; GE Medical 
Systems, Milwaukee, WI, USA). The non-contrasted CT
 
examinations  were  done  using  either  3  or  5  mm 
transverse sections
 through the posterior fossa and 5 or 
10  mm  transverse
  sections  through  the  supratentorial 
region. 
For the CTP protocol, continuous scanning of four 
adjacent 5-mm axial sections was performed with a 45-s 
cine with
 a 1-s interval, retrospectively reconstructed to a 
0.5-s
 interval, and acquired at 80 kVp using 190 mAs to 
200 mAs.
 For this examination a bolus of 40 ml contrast 
material (Ultravist, Schering, Berlin) injected at 4 ml s
-1 
was used. A 25-cm field of view was used for all the 
scans, which were reconstructed
 with a matrix of 512 x 
512  pixels.  The  scans  were  obtained  in  the
 transverse 
plane, and the examination covered the common areas of 
LA, which are the basal ganglia and the corona radiata. 
Analysis of Scans 
Two  radiologists  independently  reviewed  the  non-
contrasted  CT  scans  on  an  imaging  workstation 
(Advantage Windows; GE Medical Systems,
 Milwaukee, 
Wisconsin). The presence of LA and other lesions such 
as focal infarcts were documented. The CTP scans were 
analyzed
  by  two  radiologists  using  the  same  imaging 
workstation,  with  commercial  CTP  analysis  software 
(CTP; GE Medical Systems, Milwaukee, Wisconsin), to 
create maps of CBF, CBV and mean transit time (MTT). 
The
 more cephalad section of the 10 mm sections (x 2) or 
5 mm sections (x 4) were analyzed to maintain a uniform 
number
 of sections in all subjects.  
Both the radiologists placed ROI (3–7 mm
2) on the 
input arteries and veins at the time of evaluation of the 
scan
  by  using  the  same  protocol,  for  which  contrast-
enhancement curves were generated. For most
 patients, 
the larger of the two anterior cerebral arteries was
 chosen 
for  placement  of  the  ROI,  providing  the  arterial  input
 
function, and the superior sagittal sinus was chosen for 
placement
  of  the  ROI,  providing  the  venous  outflow 
function. These
 vessels were chosen because they can be 
identified in
 most subjects and also because their courses 
run almost perpendicular
 to the transverse plane of the 
section  used  for  the  CT  scanning  of  the
  brain.  By 
choosing  such  vessels
  errors  due  to  volume-averaging 
artifacts would be decreased. 
For  the  measurement  of  the  brain  parenchyma 
perfusion  parameters  (CBF,  CBV,  MTT),  six  small 
circular ROI were drawn on the white matter regions of 
frontal, basal ganglia and occipital lobes. The size of the 
ROI was standardized in all samples, at 120–125 mm2 
(Figure 2). The specifications were because an ROI of 
this  size  is  technically  easy  to  create  and  highly 
reproducible  during  the  post-processing  time,  and  is 
optimal  for  inclusion  and  coverage  of  most 
representative  areas  showing  white  matter  changes  in 
LA. 
Next,  the  perfusion  maps  were  created  in  the 
following  order:  CBF,  CBV  and  MTT  (Figure  3), 
following  which  the  mean  value  of  that  perfusion 
parameter  contained  within  each  of  the  six  ROI  was 
recorded.  These  mean  values  were  compared  between 
groups  1  and  2,  and  groups  3  and  4.  For  statistical 
analysis  we  used  the  Mann-Whitney  test,  with  a 
statistical significance level set at p<0.05. 
RESULTS 
Subjects 
A  total  of  49  patients  underwent  plain  CT  brain 
scan, CTA and CTP in this study. There were 23 subjects 
in the LA group and 26 in the control group. The study 
population comprised 27 females (55.1%) and 22 males 
(44.9%). The mean age for study population was 70.1 
years  (70.19  in  LA  group;  69.86  in  non-LA; 
p-value>0.05). 
The risk factor profile for patients with and without 
LA is shown in Table 1. Patients with LA showed higher 
prevalence  of  hypertension,  diabetes  mellitus, 
cardiovascular  disease  and  cerebrovascular  accidents. 
The mean MMSE score was also lower in the LA group 
(23.53), as compared to the control group (27.8), but this 
is not a considerable statistical difference (p-value>0.05). 
CT Perfusion 
CTP was successfully performed in 85.7% (n = 42; 
LA  21,  Non-LA  =  21)  of  the  cases.  However,  it  was 
unsuccessful in seven cases (LA 2, non LA 5), because 
 
Figure 2 Axial CTP scan showing six circular ROI (in purple) 
placed at both frontal, basal ganglia and occipital regions, 
indicating location of CTP measurement. N Ramli et al. Biomed Imaging Interv J 2006; 2(2):e16    4 
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of  motion  artifacts  and  technical  errors  encountered 
during the procedure. 
We found no dramatic difference between the right 
and left hemisphere CTP parameter values, and therefore 
the values of the regions of interest from both sides were 
pooled.  Mean  white  matter  values  of  frontal,  basal 
ganglia and occipital regions were obtained by averaging 
values from both sides of these regions. 
 (a) Comparison of mean perfusion parameter values 
between LA (Group1) and non-LA (Group 2) 
There was a considerable difference between of the 
mean  white  matter  CBF  between  groups  1  and  2.  In 
Group 1, it was dramatically reduced in
 patients with LA 
in the frontal by 42% (p = 0.000), basal ganglia by 37% 
(p = 0.000), and occipital regions by 18% (p = 0.019), as 
compared with Group 2 (Table 2). 
The mean white matter CBV was also considerably 
reduced in
 patients with LA in the frontal region by 36% 
(p = 0.000) and the basal ganglia by 28% (p = 0.017), but 
not in the occipital region (p = 0.289). As for the mean 
MTT values, there was no significant difference between 
groups 1 and 2 for all the regions measured. 
(b) Comparison of mean perfusion parameter values 
between dementia (group 3) and non-dementia (group 4) 
When  compared  with  Group  4,  the  mean  white 
matter  CBF  of  the  patients  in  Group  3  were  greatly 
reduced in the
 frontal region by 44% (p = 0.000), basal 
ganglia  by 32% (p = 0.038) and occipital region by 24% 
(p  =  0.001).  The  mean  white  CBV  of  patients  with 
dementia were also greatly reduced in the frontal region 
by 40% (p = 0.011) compared with the control group. 
The  mean  white  matter  MTT  values  were  also  not 
considerably different between these two groups (Table 
3).  
DISCUSSION 
The nature, pathogenesis and clinical significance of 
LA  are  not  well  understood.  Many  studies  have 
emphasized the significant correlation of this condition 
with  aging,  hypertension,  diabetes  mellitus, 
cardiovascular  disease,  cerebrovascular  accident  and 
cognitive  impairment  [1,2,8-11].  Our  study  revealed 
similar results. LA is mainly seen in the elderly in this 
study, with a mean age of 70.1 years, compared to 73.7 
years  in  a  study  by  Wiszniewska  et  al  [9].  Higher 
prevalence  of  hypertension,  diabetes  mellitus, 
cardiovascular disease and cerebrovascular accident are 
noted  in  the  LA  group  as  compared  with  the  control 
group. Aging, hypertension and diabetes mellitus induce 
arteriosclerotic changes on the small penetrating arteries 
and  arterioles  of  white  matter,  suggesting  that  LA  is 
primarily  a  small  vessels  disease.  The  correlation 
between LA and cognitive impairment is well established 
[12-14] and consistent results are observed in this study, 
where the mean MMSE score in the LA group is lower 
than in the control group.  
In  the  past,  many  researchers  have  attempted  to 
prove chronic ischemia as the pathogenesis of this entity 
using  various  imaging  modalities.  Markus  et  al  had 
shown reduced cerebral blood flow in white matter in LA 
using  quantitative  exogenous  contrast-based  perfusion 
MRI  [15].  By  using  single  photon  emission  computed 
tomography,  Starkstein  et  al  found  that  patients  with 
Alzheimer’s  disease,  and  LA  had  significant  lower 
bilateral  perfusion  in  the  basal  ganglia,  thalamus,  and 
frontal lobes than in Alzheimer patients without LA [16]. 
Miyazawa et al demonstrated reduced CBF in centrum 
semiovale of asymptomatic individuals with LA, using 
xenon-contrasted CT. Their study also demonstrated that 
the CBF values were much reduced in cases with more 
severe white matter changes [17]. CTP is a new imaging 
method  that  allows  rapid  qualitative  and  quantitative 
evaluation of cerebral perfusion, which has not been used 
in the evaluation of LA.  
 
Figure 3 CBF (A), CBV (B) and MTT (C) maps of a patient with leuko-araiosis. N Ramli et al. Biomed Imaging Interv J 2006; 2(2):e16    5 
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We  have  shown  significant  reduction  of  white 
matter CBF and CBV in patients with LA. In chronic 
ischemia, reduction in CBF is associated with reduction 
in CBV due to the loss of the autoregulatory mechanism 
of  the  involved  vessels,  in  contrast  to  acute  ischemia 
where the CBV is maintained or elevated due to an intact 
autoregulatory function. Prolongation of MTT is always 
noted in cerebral infarction due to vascular obstruction or 
sluggish flow [6]. No significant prolongation of MTT 
was  noted  in  this  study  sample,  possibly  due  to  the 
establishment of effective collateral pathways in chronic 
ischemia  that  has  shortened  the  transit  time  of  blood 
flow. Overall, these results provide further evidence for 
the role of chronic ischemia in the pathogenesis of LA. 
The absolute values of CBF obtained in the LA group 
were  similar  to  those  in  previous  studies  [15,16].  The 
mean frontal white matter CBF value in our LA group 
were  10.61  ml/min/100g,  compared  with  13.65 
ml/min/100g measured by Markus, with perfusion MRI 
[15]. Miyazawa et al showed mean centrum semiovale 
CBF values ranging from 11.31-24.27 ml/min/100g [17] 
while  our  study  obtained  values  of  10.61-20.33 
ml/min/100g. These findings suggest the validity of the 
CBF measurement using CTP. 
Our study also showed a considerable reduction of 
CBF in all regions, in Group 3. A correlation between 
cognitive  ability  and  cerebral  perfusion  had  been 
demonstrated  using  xenon-contrasted  CT,  PET  and 
SPECT  in  previous  studies  [18-20].  Meyer  et  al  used 
xenon-contrasted  CT  and  found  that  reduced  mean 
Cognitive  Capacity  Screening  examination  (CCSE) 
scores correlated directly with CBF reductions in patients 
with  multi-infarct  dementia  and  dementia  of  the 
Alzheimer’s type [18]. Terayama et al, also using xenon-
contrasted  CT,  showed  that  the  perfusion  of  cerebral 
white matter was diffusely and severely reduced in the 
frontal, temporal and occipital regions of 12 patients with 
dementia [19]. Few authors have also found that SPECT 
is able to reveal a specific pattern of cerebral perfusion 
defects, depending upon the type of dementia, allowing 
for specific diagnosis of dementia [20,21]. Our study has 
shown that CTP is a valid and useful imaging modality 
with  the  ability  to  demonstrate  cerebral  perfusion 
changes in patients with dementia. Thus, coupled with 
clinical assessment, CTP should potentially enhance the 
diagnostic accuracy of dementia. However, our study has 
not  been  designed  to  analyze  CTP  among  the  various 
types of dementia, and clinical grading of dementia from 
mild to severe is expected to affect the CTP data. Further 
study with a larger sample of patients with dementia, and 
a study design that allows differentiation of various types 
of dementia is warranted. This can further investigate the 
feasibility  of  CTP  as  a  useful  imaging  method  in 
diagnosing specific types of dementia, which had been 
shown possible with SPECT.   
CONCLUSION 
CTP  is  a  non-invasive,  fast,  easy-to-perform 
imaging tool, which is valid and comparable with other 
imaging  modalities  in  measuring  cerebral  perfusion  in 
patients with LA and dementia. By using CTP, we have 
shown significant reduced white matter CBF and CBV in 
patients  with  LA.  This  is  consistent  with  chronic 
ischemia  as  the  pathogenesis  of  LA.  We  have  also 
demonstrated that CTP is a potentially important clinical 
imaging technique in the diagnosis and management of 
dementia,  in  view  of  its  ability  to  show  significant 
cerebral hypoperfusion in these patients.  
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Table 1 Risk factors profile for patients with or without leukoaraiosis 
Characteristic  LA 
( n = 23 ) 
Non LA 
( n = 26 ) 
Age, mean  70.19  69.86 
Age, range  51-87  51-80 
Female  12 (52.2%)  15 (57.7%) 
Male  11 (47.8%)  11 (40.7%) 
Hypertension  15 (65.2%)  9 (34.6%) 
Diabetes mellitus  9 (39.4%)  7 (26.9%) 
CVD  8 (34.8%)  2 (7.7%) 
CVA  17 (73.9%)  9 (34.6%) 
Mean MMSE  23.53 / 30  27.83 / 30 
      CVD= cardiovascular disease 




Table 2 Mean CBF values (ml/min/100g), Mean CBV values (ml/100g) and MTT (sec) in the leukoaraiosis and the non- leukoaraiosis groups 
CBF  CBV  MTT  Region 
LA  Non LA  LA  Non LA  LA  Non LA 
10.61  18.47  0.87  1.38  5.59  5.05  Mean frontal WM 
p=0.000  p=0.000  NS 
20.33  32.47  1.42  1.99  4.98  4.29  Mean basal ganglia WM 
p=0.000  p=0.017  NS 
15.31  18.74  1.25  1.41  5.72  5.30  Mean occipital WM 
p=0.019  NS  NS 




Table 3 Mean CBF values ( ml/min/100g), Mean CBV values (ml/100g) and MTT (sec) in dementia and non-dementia patients 
CBF  CBV  MTT  Region 
Dementia  Non- 
dementia 
Dementia  Non- 
dementia 
Dementia  Non- 
dementia 
11.90  21.26  12.93  22.05  20.07  17.50  Mean frontal WM  
p=0.000  p=0.011  NS 
24.32  36.03  16.00  20.09  20.07  17.50  Mean basal ganglia WM 
p=0.038  NS   NS  
15.47  20.56  13.79  21.50  19.32  17.98  Mean occipital WM 
p=0.001  NS   NS  
       WM = white matter , NS = not significant 